skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Deoxycytidine Analogue TAS-109 (Code C82697)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Deoxycytidine Analogue TAS-109

Definition: An analogue of the nucleoside deoxycytidine with potential antineoplastic activity. Nucleoside analogue TAS-109 is incorporated into DNA and directly inhibits the activity of DNA polymerase, which may result in inhibition of DNA replication and cell cycle arrest in the S and G2/M phases, DNA fragmentation, and tumor cell apoptosis.

Display Name: Deoxycytidine Analogue TAS-109

Label: Deoxycytidine Analogue TAS-109

NCI Thesaurus Code: C82697 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL388479  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Deoxycytidine Analogue TAS-109

External Source Codes: 
PDQ Closed Trial Search ID 633936
PDQ Open Trial Search ID 633936 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C82697
Contributing_Source CTRP
Legacy_Concept_Name Deoxycytidine_Analogue_TAS-109
Semantic_Type Nucleic Acid, Nucleoside, or Nucleotide
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom